• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Progen Pharmaceuticals Ltd

+ Add to Watchlist

PGL:AU

0.1950 AUD 0.0050 2.50%

As of 01:50:28 ET on 10/02/2014.

Snapshot for Progen Pharmaceuticals Ltd (PGL)

Open: 0.2200 Day's Range: 0.1950 - 0.2200 Volume: 23,365
Previous Close: 0.2000 52wk Range: 0.1900 - 1.2900 1-Yr Rtn: -15.22%

Stock Chart for PGL

No chart data available.
  • PGL:AU 0.1950
  • 1D
  • 1M
  • 1Y
0.2000
Interactive PGL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PGL

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -0.0327
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 10.78
Shares Outstanding (M) 55.29
30 Day Average Volume 37,716
Price/Book (mrq) 1.3452
Price/Sale (ttm) 1.9922
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PGL

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for PGL

Progen Pharmaceuticals Limited is involved in the discovery, research and development of potential biopharmaceutical therapeutics for the treatment of human diseases. The Company also provides contract services related to the process development, manufacture and quality assurance of biological products.

Indrajit Solomon Arulampalam "Jitto"ChairmanHeng Hsin TangActing Managing Director
Lee HorobinGen Mgr:FinanceFleur LankesheerDir:Bus Development & Legal
More Company Profile & Key Executives for PGL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil